Arrowstreet Capital, Limited Partnership Surmodics Inc Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Surmodics Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 32,606 shares of SRDX stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,606

Previous 29,316 11.22%

Holding current value

$1.29 Million

Previous $1.23 Million 2.6%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$38.47 - $42.24 $126,566 - $138,969	3,290 Added 11.22%	32,606 $1.26 Million
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $350,038 - $473,234	-12,295 Reduced 29.55%	29,316 $1.07 Million
Q3 2023 Nov 14, 2023	SELL	$28.28 - $38.36 $2.13 Million - $2.89 Million	-75,336 Reduced 64.42%	41,611 $1.34 Million
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $10,584 - $18,754	599 Added 0.51%	116,947 $3.66 Million
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $1.99 Million - $4.48 Million	116,348 New	116,348 $2.65 Million
Q1 2022 May 13, 2022	SELL	$40.68 - $49.72 $431,085 - $526,882	-10,597 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$52.8 - $60.32 $81,523 - $93,134	-1,544 Reduced 12.72%	10,597 $589,000
Q2 2021 Aug 13, 2021	SELL	$51.29 - $59.15 $340,873 - $393,110	-6,646 Reduced 35.38%	12,141 $659,000
Q1 2021 May 14, 2021	SELL	$42.18 - $56.07 $323,731 - $430,337	-7,675 Reduced 29.0%	18,787 $1.05 Million
Q4 2020 Feb 12, 2021	BUY	$35.18 - $43.52 $137,342 - $169,902	3,904 Added 17.31%	26,462 $1.15 Million
Q3 2020 Nov 12, 2020	BUY	$37.98 - $48.72 $78,238 - $100,363	2,060 Added 10.05%	22,558 $878,000
Q2 2020 Aug 12, 2020	BUY	$31.07 - $44.74 $636,872 - $917,080	20,498 New	20,498 $886,000
Q2 2019 Aug 14, 2019	SELL	$38.23 - $47.43 $2.39 Million - $2.96 Million	-62,410 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$41.26 - $58.35 $1.02 Million - $1.44 Million	-24,763 Reduced 28.41%	62,410 $2.71 Million
Q4 2018 Feb 14, 2019	SELL	$44.93 - $73.38 $2.32 Million - $3.79 Million	-51,615 Reduced 37.19%	87,173 $4.12 Million
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $1.32 Million - $1.86 Million	23,177 Added 20.05%	138,788 $10.4 Million
Q2 2018 Aug 14, 2018	BUY	$35.85 - $57.05 $1.04 Million - $1.65 Million	28,931 Added 33.38%	115,611 $6.38 Million
Q1 2018 May 14, 2018	SELL	$27.0 - $38.5 $307,800 - $438,900	-11,400 Reduced 11.62%	86,680 $3.3 Million
Q3 2017 Nov 14, 2017	BUY	$24.5 - $31.1 $2.4 Million - $3.05 Million	98,080	98,080 $3.04 Million

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

11.8M

Call Options Held

1.4K

Put Options Held

8.6K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $553M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Surmodics Inc Transaction History